The Institute of Medicine has identified prevention of birth defects as one of six priorities for the nation's? health because annually, 150,000 infants (1% - 3% of all U.S. births) are born with some form of physical or? mental birth defect. It is estimated that each year, 12 million US women use medications that increase the risk? of birth defects. With concurrent use of contraception, birth defects associated with these medications can be? prevented. Unfortunately, when prescribing these medications, clinicians rarely counsel women about? contraception, and approximately 6% of US pregnancies are exposed to medications that may increase risk of? birth defects. As Health IT has improved the safety of medication management in some healthcare settings, we? propose to develop and then rigorously evaluate ways computers may be able to help doctors counsel women? about preventing birth defects caused by use of certain medications. To better understand what information? about risk of medication-induced birth defects would be most useful to primary care clinicians and their? patients, we will begin this project by conducting a series of focus groups with clinicians and patients seen in? academic and community-based practices. Data from these discussions will help refine the two Health IT? interventions we will develop. We will evaluate the impact of each of these interventions using a factorial? design randomized controlled trial. In the first trial, we will compare multi-faceted decision support? (intervention) to streamlined clinical alerts (control). In the second trial, we will evaluate whether collecting? machine-actionable information about women?s risk of pregnancy using a networked tablet computer? (intervention) is superior to the way clinicians usually collect this information (control).? Over the course of 1 year, we will abstract data from the electronic medical record when study? clinicians prescribe teratogenic medications (N=1500), conduct phone interviews with women (N=800)? prescribed medications by participating clinicians, and survey participating clinicians (N=100) about their? satisfaction with the decision support they receive. We will use this data to confirm our hypotheses that? clinicians in the intervention groups will (1) prescribe fewer teratogenic medications, (2) be more likely to? prescribe contraception when a teratogenic medication is prescribed, (3) have more patients report satisfaction? with the counseling they received, and (4) report more satisfaction with the decision support they received.? This evaluation will provide much-needed information on how Health IT can best be harnessed to prevent? medication-induced birth defects nationwide. In addition, the Health IT intervention shown to be most effective? will be disseminated within the University of Pittsburgh Medical Center, which provides 3 million outpatient? visits each year.?

Agency
National Institute of Health (NIH)
Institute
Agency for Healthcare Research and Quality (AHRQ)
Type
Research Demonstration and Dissemination Projects (R18)
Project #
5R18HS017093-02
Application #
7493505
Study Section
Special Emphasis Panel (ZHS1-HSR-A (01))
Program Officer
Johnson, Heather A
Project Start
2007-09-07
Project End
2010-08-31
Budget Start
2008-09-01
Budget End
2009-08-31
Support Year
2
Fiscal Year
2008
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Lee, Jessica K; Parisi, Sara M; Schwarz, Eleanor Bimla (2013) Contraceptive Counseling and Use among Women with Poorer Health. J Womens Health Issues Care 2:103
Schwarz, Eleanor Bimla; Parisi, Sara M; Handler, Steven M et al. (2013) Counseling about medication-induced birth defects with clinical decision support in primary care. J Womens Health (Larchmt) 22:817-24
Russo, Jennefer A; Parisi, Sara M; Kukla, Kathryn et al. (2013) Women's information-seeking behavior after receiving contraceptive versus noncontraceptive prescriptions. Contraception 87:824-9
Schwarz, Eleanor Bimla; Parisi, Sara M; Williams, Sanithia L et al. (2012) Promoting safe prescribing in primary care with a contraceptive vital sign: a cluster-randomized controlled trial. Ann Fam Med 10:516-22
Chuang, Cynthia H; Martenis, Melissa E; Parisi, Sara M et al. (2012) Contraception and abortion coverage: What do primary care physicians think? Contraception 86:153-6
Parisi, Sara M; Zikovich, Shannon; Chuang, Cynthia H et al. (2012) Primary care physicians' perceptions of rates of unintended pregnancy. Contraception 86:48-54
Schwarz, Eleanor Bimla; Parisi, Sara M; Handler, Steven M et al. (2012) Clinical decision support to promote safe prescribing to women of reproductive age: a cluster-randomized trial. J Gen Intern Med 27:831-8
Lee, Jessica K; Parisi, Sara M; Akers, Aletha Y et al. (2011) The impact of contraceptive counseling in primary care on contraceptive use. J Gen Intern Med 26:731-6
Santucci, Aimee K; Gold, Melanie A; Akers, Aletha Y et al. (2010) Women's perspectives on counseling about risks for medication-induced birth defects. Birth Defects Res A Clin Mol Teratol 88:64-9
Akers, Aletha Y; Gold, Melanie A; Borrero, Sonya et al. (2010) Providers' perspectives on challenges to contraceptive counseling in primary care settings. J Womens Health (Larchmt) 19:1163-70

Showing the most recent 10 out of 11 publications